Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation

Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation

Bibliographic Details
Main Authors:	Nigam Shah, Agata Foryciarz, Stephen R Pfohl, Birju Patel
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-04-01
Series:	BMJ Health & Care Informatics
Online Access:	https://informatics.bmj.com/content/29/1/e100460.full

Similar Items

A comparison of approaches to improve worst-case predictive model performance over patient subpopulations
by: Pfohl, Stephen R, et al.
Published: (2022)

Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular Disease
by: Sha Li, et al.
Published: (2022-04-01)

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
by: Xiaoling Cai, et al.
Published: (2022-11-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

Algorithmic fairness in cardiovascular disease risk prediction: overcoming inequalities
by: Tibor V Varga
Published: (2023-11-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Dyslipidemia and Management of Atherosclerotic Cardiovascular Diseases in China: New Evidence and New Guidelines
by: Dayi Hu
Published: (2017-01-01)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
by: Da-Yi Hu
Published: (2017-06-01)

Residual risk in patients with atherosclerotic cardiovascular disease
by: E. V. Khazova, et al.
Published: (2023-02-01)

Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
by: Yu En, et al.
Published: (2018-05-01)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
by: Pierre Gourdy, et al.
Published: (2023-09-01)

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
by: Gunilla Journath, et al.
Published: (2017-08-01)

Comparison of Innovative and Traditional Cardiometabolic Indices in Estimating Atherosclerotic Cardiovascular Disease Risk in Adults
by: Ya-Chin Huang, et al.
Published: (2021-03-01)

Sex Associations Between Air Pollution and Estimated Atherosclerotic Cardiovascular Disease Risk Determination
by: Alexandre Vallée
Published: (2023-09-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Prediction performance and fairness heterogeneity in cardiovascular risk models
by: Uri Kartoun, et al.
Published: (2022-07-01)

Estimating the efficacy of symptom-based screening for COVID-19
by: Alison Callahan, et al.
Published: (2020-07-01)

Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
by: Alfredo Mauriello, et al.
Published: (2023-11-01)

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
by: Xue-Li Yang, et al.
Published: (2016-06-01)

EHR foundation models improve robustness in the presence of temporal distribution shift
by: Lin Lawrence Guo, et al.
Published: (2023-03-01)

Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
by: Erin S. Mackinnon, et al.
Published: (2024-01-01)

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies
by: Jernej Jeras, et al.
Published: (2022-12-01)

Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment
by: Raul-Alexandru Jigoranu, et al.
Published: (2023-07-01)

Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
by: Liv Tybjærg Nordestgaard, et al.
Published: (2022-08-01)

Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction
by: Geeta Sikand, MA, RDN, FAND, CDE, CLS, FNLA, et al.
Published: (2020-12-01)

Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk
by: Nevine I. Musa, et al.
Published: (2019-09-01)

The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease
by: Diede Smeets, et al.
Published: (2022-04-01)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - Is the new guideline based on best evidence?
by: Canoy, D
Published: (2014)

Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - is the new guideline based on best evidence?
by: Canoy, D
Published: (2014)

GUIDELINE ON THE MANAGEMENT OF BLOOD CHOLESTEROL: TOP 10 TAKE-HOME MESSAGES TO REDUCE RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE THROUGH CHOLESTEROL MANAGEMENT
by: S. M. Grundy, et al.
Published: (2019-09-01)

Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
by: Latifah Alothman, MD, et al.
Published: (2019-07-01)

Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population
by: Sangwoo Park, et al.
Published: (2023-05-01)

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
by: Reed Mszar, et al.
Published: (2023-02-01)

Common variable immunodeficiency—an independent risk factor for atherosclerotic cardiovascular diseases
by: Juho Mattila, et al.
Published: (2023-11-01)

DIFFERENCES IN LIPOPROTEIN(A) BY RACE, ETHNICITY, AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
by: Ramzi Dudum, MD MPH, et al.
Published: (2023-09-01)

Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk
by: Deepak Palakshappa, et al.
Published: (2021-11-01)

Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit.
by: Olivier Boucheix, et al.
Published: (2016-01-01)

Digital interventions in the treatment of cardiovascular risk factors and atherosclerotic vascular disease
by: Martin Steinmetz, et al.
Published: (2020-02-01)

Cohort study on the effects of depression on atherosclerotic cardiovascular disease risk in Korea
by: Yon Ho Jee, et al.
Published: (2019-06-01)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
by: Lei Bi, et al.
Published: (2022-03-01)